Nile Pharma’s OGM nods to dividends payment for FY 2020/2021
Updated 10/6/2021 11:01:09 AM
ArabFinance: El Nile Company for Pharmaceuticals and Chemical Industries (Nile Pharma) (NIPH) announced that its ordinary general meeting (OGM) approved the distribution of cash dividends worth EGP 2 per share to shareholders for fiscal year (FY) 2020/2021, according to a statement filed to the Egyptian Exchange (EGX).
It is worth Nile Pharma previously reported a net profit of EGP 66.426 million in FY 2020/2021, compared to EGP 93.384 million in FY 2019/2020.
Nile Pharma manufactures and markets pharmaceuticals, various types of medical materials, chemical products, and cosmetics, as well as surgical threads and medical solutions.
